Hecht Beth

CIK 00016524105 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001652410

Recent Transactions

50 trades

Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-01-02$7.43/sh−16,667→ 1,308,103 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-12-01$7.01/sh−16,667→ 1,320,176 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-11-11$7.40/sh−16,667→ 1,336,843 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-03-20$5.43/sh−40,000→ 1,353,510 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−45,909→ 1,306,885 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Appreciation Right
2025-01-31+300,000→ 300,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31+185,000→ 1,393,510 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−98,375→ 1,208,510 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-03$3.61/sh−32,039→ 1,352,794 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31$2.46/sh−45,909→ 1,380,802 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31+750,000→ 1,554,968 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-29$2.66/sh−19,675→ 1,426,711 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-03$2.24/sh−33,488→ 1,446,386 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-06-15+15,853→ 18,839 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-06-15−15,853→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+350,000→ 797,758 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31$1.24/sh−5,784→ 1,479,874 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-29$1.26/sh−21,177→ 1,485,658 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-03$1.12/sh−33,488→ 1,506,835 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-06-23+36,798→ 44,805 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-23−36,798→ 0 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-15$0.01/sh+237,795→ 237,795 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-03-18−7,642→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-18+7,642→ 8,007 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-31$2.11/sh−4,448→ 1,540,323 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-29$2.11/sh−14,037→ 1,544,771 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+225,000→ 436,821 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−32,500→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−26,366→ 180,000 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−30,879→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−3,826→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−65,295→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−150,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−180,000→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+26,366→ 26,366 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+180,000→ 206,366 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+30,879→ 30,879 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+32,500→ 32,500 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+150,000→ 150,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+65,295→ 65,295 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+3,826→ 3,826 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2021-06-23+36,798→ 36,798 total
Award
AYTU BIOPHARMA, INC$AYTU
Common Stock
2021-04-08+6,500→ 9,052 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−46,907→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−14,777→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−22,756→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−18,322→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Common Stock
2021-03-19−23,453→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−12,500→ 0 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2021-03-18+7,642→ 7,642 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov